Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Alexandria Venture

Founders Joel Marcus

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 41
Average round size
info
The average size of a deal this fund participated in
$38M
Portfolio companies 36
Rounds per year 1.52
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.12
Exits 15
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
Summary

The fund was located in North America if to be more exact in United States. Alexandria Venture appeared to be a CVC structure as part of the corporation. The leading representative office of defined VC is situated in the San Francisco.

The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2018. This Alexandria Venture works on 6 percentage points less the average amount of lead investments comparing to the other organizations. The fund is generally included in 2-6 deals every year. Considering the real fund results, this VC is 14 percentage points less often commits exit comparing to other organizations. The important activity for fund was in 2016. Despite it in 2019 the fund had an activity.

This organization was formed by Joel Marcus.

Among the most popular portfolio startups of the fund, we may highlight Relay Therapeutics, Vividion Therapeutics, Synthego. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Health Care, Therapeutics.

The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Alexandria Venture, startups are often financed by Flagship Pioneering, ARCH Venture Partners, Polaris Partners. The meaningful sponsors for the fund in investment in the same round are ARCH Venture Partners, Pfizer Venture Investments, Polaris Partners. In the next rounds fund is usually obtained by Polaris Partners, iSELECT FUND, Lundbeckfonden Ventures.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Alexandria Venture:
Typical Co-investors
Alexandria Venture is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Alexandria Venture:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Radiant Biotherapeutics

Biotechnology
Therapeutics
$8M25 Apr 2023 Toronto, Ontario, Canada

Tiamat Sciences

AgTech
Biotechnology
Food and Beverage
Medical
$2M09 Mar 2023 Berkeley, California, United States

Kojin Therapeutics

Biopharma
Biotechnology
Life Science
Medical
$60M09 Jun 2021 Cambridge, Massachusetts, United States

TARA Biosystems

Biotechnology
Medical
$10M23 Jun 2020 New York, New York, United States

Crop Enhancement

Agriculture
Chemical
Farming
$8M14 Apr 2020 San Jose, California, United States

Triplet Therapeutics

Biotechnology
Health Care
$49M17 Dec 2019 Cambridge, Massachusetts, United States

Immunitas Therapeutics

Biotechnology
Life Science
Therapeutics
$39M21 Nov 2019 Cambridge, Massachusetts, United States

Relay Therapeutics

Biotechnology
Health Care
Therapeutics
$400M20 Dec 2018 Cambridge, Massachusetts, United States

Nohla Therapeutics

Biotechnology
Health Diagnostics
Therapeutics
$11M12 Jul 2018 Seattle, Washington, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Alexandria Venture?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 41
Average round size 38M
Rounds per year 1.52
Peak activity year 2016
Lead investments 1
Follow on index 0.12
Exits 15
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Radiant Biotherapeutics

Biotechnology
Therapeutics
$8M25 Apr 2023 Toronto, Ontario, Canada

Tiamat Sciences

AgTech
Biotechnology
Food and Beverage
Medical
$2M09 Mar 2023 Berkeley, California, United States

Kojin Therapeutics

Biopharma
Biotechnology
Life Science
Medical
$60M09 Jun 2021 Cambridge, Massachusetts, United States

TARA Biosystems

Biotechnology
Medical
$10M23 Jun 2020 New York, New York, United States

Crop Enhancement

Agriculture
Chemical
Farming
$8M14 Apr 2020 San Jose, California, United States

Triplet Therapeutics

Biotechnology
Health Care
$49M17 Dec 2019 Cambridge, Massachusetts, United States

Immunitas Therapeutics

Biotechnology
Life Science
Therapeutics
$39M21 Nov 2019 Cambridge, Massachusetts, United States

Relay Therapeutics

Biotechnology
Health Care
Therapeutics
$400M20 Dec 2018 Cambridge, Massachusetts, United States

Nohla Therapeutics

Biotechnology
Health Diagnostics
Therapeutics
$11M12 Jul 2018 Seattle, Washington, United States
Crunchbase icon

Content report

The following text will be sent to our editors: